Indivior Publishes Design and Patient Characteristics for Real-World Study of Life Changes in People Treated with SUBLOCADE™ (Buprenorphine Extended-Release) in Contemporary Clinical Trials - PRNewswire

Submitted by Anonymous (not verified) on Thu, 12/20/2018 - 14:04

Indivior Publishes Design and Patient Characteristics for Real-World Study of Life Changes in People Treated with SUBLOCADE™ (Buprenorphine Extended-Release) in Contemporary Clinical Trials  PRNewswireSLOUGH, England and RICHMOND, Va., Dec. 20, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of the study design and ...